CXCL8 and neoplasm: Blocking the NF-κB pathway activated IL-8 secretion via the small molecule BAY 11-7082 in PTC cells, and the IL-8 antagonist SB225002 could eliminate chemotaxis for tumor-associated neutrophils in the TME of PTC to inhibit PTC growth and metastasis [190].